logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Fosun Pharma (02196.HK) repurchased 1 million shares for HK$17.193 million on September 17.

date
17/09/2026
Zhitong Finance APP News, Fosun Pharma (02196.HK) announced that on September 17, 2026, the company spent HK$17.193 million to repurchase 1 million shares.
Latest
2 m ago
China Beidahuang (00039.HK) appoints Zhonghui Anda Risk Management as independent internal control consultant
2 m ago
MINISO (09896.HK) repurchased 106,000 shares for approximately HK$1.8381 million on September 17.
2 m ago
BSBE (300406.SZ) investee company Zhongke Natai plans to implement equity restructuring.
3 m ago
Stifel: Raises Salesforce (CRM.N) price target from $275 to $300.
3 m ago
US Stock Movement | Generac (GNRC.US) Surges Nearly 35% in Pre-Market Trading; Amazon Generator Mega Order Wins Analyst Optimism
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.